CYTOTOXIC DRUGS CONTRACT MANUFACTURING MARKET ANALYSIS

Regional Analysis

Cytotoxic Drugs Contract Manufacturing Market - Regional Analysis

Among regions, North America cytotoxic drugs contract manufacturing market is expected to account for the largest market share over the forecast period, owing to increasing prevalence of cancer in the region. For instance, according to the National Cancer Institute, 2016, the number of new cancer cases per year is expected to increase to 23.6 million by 2030, globally. Moreover, according to the National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024 globally.  

Moreover, Europe is expected to account for significant market share in the global cytotoxic drugs contract manufacturing market over the forecast period, owing to implementation of government regulations and growing incidence of cancer in the region. For instance in 2018, according to the World Health Organization, around 4,229,662 new cases of cancer were diagnosed in Europe. Moreover, in 2016, new policy recommendations on preventing occupational exposure to cytotoxic drugs were launched in the European Parliament, which was an initiative designed to protect healthcare professionals working across the European Union. This was undertaken as unsafe handling of cytotoxic drugs could cause cancer, organ toxicity, fertility problems, genetic damage, and birth defects.